Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Clinical trial NCT04896853 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04896853
Sponsor: NextCell Pharma Ab
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Acute Respiratory Distress Syndrome Influenza A Metapneumovirus Pneumonia Respiratory Syncytial Virus (RSV)

Start date: 2021-05-18
Primary completion: 2027-03-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.